Head-To-Head Review: Marrone Bio Innovations (MBII) vs. Israel Chemicals Shs (ICL)
Marrone Bio Innovations (NASDAQ: MBII) and Israel Chemicals Shs (NYSE:ICL) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.
This table compares Marrone Bio Innovations and Israel Chemicals Shs’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Marrone Bio Innovations||-177.10%||N/A||-64.21%|
|Israel Chemicals Shs||-3.43%||13.55%||4.20%|
Institutional & Insider Ownership
51.1% of Marrone Bio Innovations shares are owned by institutional investors. Comparatively, 6.0% of Israel Chemicals Shs shares are owned by institutional investors. 7.3% of Marrone Bio Innovations shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Israel Chemicals Shs pays an annual dividend of $0.10 per share and has a dividend yield of 2.4%. Marrone Bio Innovations does not pay a dividend. Israel Chemicals Shs pays out -66.7% of its earnings in the form of a dividend.
Earnings & Valuation
This table compares Marrone Bio Innovations and Israel Chemicals Shs’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Marrone Bio Innovations||$16.95 million||1.79||-$21.12 million||($1.17)||-0.83|
|Israel Chemicals Shs||$5.34 billion||1.01||$924.80 million||($0.15)||-28.20|
Israel Chemicals Shs has higher revenue and earnings than Marrone Bio Innovations. Israel Chemicals Shs is trading at a lower price-to-earnings ratio than Marrone Bio Innovations, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings and target prices for Marrone Bio Innovations and Israel Chemicals Shs, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Marrone Bio Innovations||0||2||1||0||2.33|
|Israel Chemicals Shs||0||2||0||0||2.00|
Marrone Bio Innovations currently has a consensus price target of $2.50, suggesting a potential upside of 157.73%. Israel Chemicals Shs has a consensus price target of $4.88, suggesting a potential upside of 15.25%. Given Marrone Bio Innovations’ stronger consensus rating and higher probable upside, equities analysts plainly believe Marrone Bio Innovations is more favorable than Israel Chemicals Shs.
Volatility and Risk
Marrone Bio Innovations has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. Comparatively, Israel Chemicals Shs has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500.
Israel Chemicals Shs beats Marrone Bio Innovations on 9 of the 15 factors compared between the two stocks.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
About Israel Chemicals Shs
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash and salt from subterranean mines in Spain and the United Kingdom, as well as uses part of the potash to produce compound fertilizers; mines and processes phosphate rock in open mines; and produces sulfuric acid, agricultural phosphoric acid, phosphate fertilizers, compound fertilizers, liquid fertilizers, and soluble fertilizers. It also manufactures compound fertilizers in the Netherlands, Germany, and Belgium; liquid fertilizers and soluble fertilizers in Spain; slow release and controlled release fertilizers in the Netherlands and the United States; and phosphate-based food additives for livestock in Turkey and Israel. In addition, the company produces bromine out of a solution that is created as a by-product of the potash production process in Sodom, as well as bromine-based products; chlorine-based products in Israel and the United States; and flame retardants and phosphorus based products, as well as extracts salt, magnesia, and chlorine from Dead Sea brine. Further, it purchases clean phosphoric acid and manufactures thermal phosphoric acids, which are used to manufacture downstream products and phosphate salts that are used as a raw material for manufacturing, food additives, hygiene products and flame retardants, and fire extinguishment products. It also manufactures phosphorous derivatives based on phosphorous; specialty products based on aluminum acids; and other raw materials. The company sells its products through marketing companies, agents, and distributors. Israel Chemicals Ltd. was founded in 1968 and is headquartered in Tel Aviv, Israel.
Receive News & Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.